Trial intelligence / Profile preview

Crizotinib Phase 2 Trial in Japan

jRCT2080221069Phase 2Completed

Start
Apr 2010
Modality
Small Molecules
01

Overview

A Phase 2 trial of crizotinib in cancer. Started Apr 2010; status: completed.

02

Drugs

crizotinib
03

Conditions

cancer

Beyond the preview

Go deeper on jRCT2080221069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call